Everything Sophos Biotech does is wholly aimed at following ethical standards in which the first and main objective is to meet the customers and the patients’ needs. To do this, Sophos Biotech is committed every day to recommending and actively promoting a high professional standard.
Primo ed unico dispositivo medico nella prevenzione delle mucositi.
Mucositis Therapy
gelX® Oral Spray
Flacone da 100 ml
gelX® Oral Spray is mainly composed of Polyvinylpyrrolidone (PVP), Zinc Gluconate and Taurine. Unlike similar products on the market, in addition to generating a protective barrier, thanks to the soothing and anti-oxidant properties of zinc and taurine, is able to accelerate the process of healing the mucosa.
Breast Oncology
EXTROPLEX 1 mg
FILM-COATED TABLETS
ANASTROZOLE
GENERIC
EXTROPLEX contains a substance called anastrozole that belongs to a group of drugs called “aromatase inhibitors.”
Breast Oncology
LETRIX 2,5 mg
FILM-COATED TABLETS
LETROZOLE
GENERIC
LETRIX contains a substance called letrozole that belongs to a group of drugs called “aromatase inhibitors.”
Breast Oncology
MESTANE 25 mg
COATED TABLETS
Exemestane
GENERIC
MESTANE belongs to the category of drugs known as “aromatase inhibitors.”
Breast Oncology
MEGEXIA 160 mg
TABLETS
MEGESTROL ACETATE
GENERIC
MEGEXIA is a drug whose active ingredient is megestrol, which belongs to a group of drugs used for hormone therapy in the treatment of certain types of cancers.
Prostate Oncology
Politrate 3,75 mg
POLITRATE 3.75 mg is a medicinal product whose active ingredient is leuprorelin, belonging to a group of medicines used in hormone therapy. It is used in the treatment of hormone-sensitive conditions, such as certain forms of prostate cancer.
Prostate Oncology
Politrate 22,5 mg
POLITRATE 22.5 mg is a medicinal product whose active ingredient is leuprorelin, belonging to the class of medicines used in hormone therapy. It is indicated for the treatment of hormone-dependent conditions, including certain types of prostate cancer.
Prostate Oncology
Midelut 50 mg
MIDELUT 50 mg is a medicinal product whose active ingredient is bicalutamide, belonging to a group of medicines used in hormonal cancer therapy. It is used in the treatment of prostate cancer, often in combination with other specific therapies.
Prostate Oncology
Midelut 150 mg
MIDELUT 150 mg is a medicinal product whose active ingredient is bicalutamide, belonging to the class of antiandrogens used in hormone therapy. It is indicated for the treatment of prostate cancer, helping to counteract the action of male hormones.